New Insights into Exosome Mediated Tumor-immune Escape: Clinical Perspectives and Therapeutic Strategies

Overview

Journal Biochim Biophys Acta Rev Cancer

Publisher Elsevier

Specialties Biochemistry
Biophysics
Oncology

Date 2021 Sep 6

PMID 34487817

Citations 21

Authors

Anup S Pathania

Philip Prathipati

Kishore B Challagundla

Affiliations

Soon will be listed here.

Abstract

Recent advances in extracellular vesicle biology have uncovered a substantial role in maintaining cell homeostasis in health and disease conditions by mediating intercellular communication, thus catching the scientific community's attention worldwide. Extracellular microvesicles, some called exosomes, functionally transfer biomolecules such as proteins and non-coding RNAs from one cell to another, influencing the local environment's biology. Although numerous advancements have been made in treating cancer patients with immune therapy, controlling the disease remains a challenge in the clinic due to tumor-driven interference with the immune response and inability of immune cells to clear cancer cells from the body. The present review article discusses the recent findings and knowledge gaps related to the role of exosomes derived from tumors and the tumor microenvironment cells in tumor escape from immunosurveillance. Further, we highlight examples where exosomal non-coding RNAs influence immune cells' response within the tumor microenvironment and favor tumor growth and progression. Therefore, exosomes can be used as a therapeutic target for the treatment of human cancers.

Citing Articles

Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma.

Guan M, Wang M, Wang W, Li C, Yao L, Zhu H Liver Res. 2025; 6(3):132-138.

PMID: 39958202 PMC: 11791807. DOI: 10.1016/j.livres.2022.08.001.

Relationship between exosomes and cancer: formation, diagnosis, and treatment.

Huang C, Li J, Xie Z, Hu X, Huang Y Int J Biol Sci. 2025; 21(1):40-62.

PMID: 39744442 PMC: 11667803. DOI: 10.7150/ijbs.95763.

Glioma-Derived Exosomes and Their Application as Drug Nanoparticles.

Mastantuono S, Manini I, Di Loreto C, Beltrami A, Vindigni M, Cesselli D Int J Mol Sci. 2024; 25(23).

PMID: 39684236 PMC: 11641060. DOI: 10.3390/ijms252312524.

Unveiling exosomes: Cutting-edge isolation techniques and their therapeutic potential.

Sani F, Shafiei F, Dehghani F, Mohammadi Y, Khorraminejad-Shirazi M, Anvari-Yazdi A J Cell Mol Med. 2024; 28(20):e70139.

PMID: 39431552 PMC: 11492151. DOI: 10.1111/jcmm.70139.

Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma.

Stefanovic M, Jovanovic I, Zivkovic M, Stankovic A PLoS One. 2024; 19(6):e0305042.

PMID: 38861512 PMC: 11166308. DOI: 10.1371/journal.pone.0305042.

References

Xu L, Huang Y, Tan L, Yu W, Chen D, Lu C . Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma. Int Immunopharmacol. 2015; 29(2):635-641. DOI: 10.1016/j.intimp.2015.09.017. View

Wu J, Gao W, Tang Q, Yu Y, You W, Wu Z . M2 Macrophage-Derived Exosomes Facilitate HCC Metastasis by Transferring α β Integrin to Tumor Cells. Hepatology. 2020; 73(4):1365-1380. PMC: 8360085. DOI: 10.1002/hep.31432. View

Wang Z, Hill S, Luther J, Hachey D, Schey K . Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT). Proteomics. 2011; 12(2):329-38. PMC: 3517144. DOI: 10.1002/pmic.201100477. View

Munich S, Sobo-Vujanovic A, Buchser W, Beer-Stolz D, Vujanovic N . Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. Oncoimmunology. 2012; 1(7):1074-1083. PMC: 3494621. DOI: 10.4161/onci.20897. View

Haraszti R, Didiot M, Sapp E, Leszyk J, Shaffer S, Rockwell H . High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016; 5:32570. PMC: 5116062. DOI: 10.3402/jev.v5.32570. View

Chava S, Reynolds C, Pathania A, Gorantla S, Poluektova L, Coulter D . miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Mol Oncol. 2019; 14(1):180-196. PMC: 6944109. DOI: 10.1002/1878-0261.12588. View

Ho A, Brana I, Haddad R, Bauman J, Bible K, Oosting S . Tipifarnib in Head and Neck Squamous Cell Carcinoma With Mutations. J Clin Oncol. 2021; 39(17):1856-1864. PMC: 8189627. DOI: 10.1200/JCO.20.02903. View

Yang Y, Li C, Chan L, Wei Y, Hsu J, Xia W . Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res. 2018; 28(8):862-864. PMC: 6082826. DOI: 10.1038/s41422-018-0060-4. View

Domvri K, Petanidis S, Anestakis D, Porpodis K, Bai C, Zarogoulidis P . Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance via immunosuppressive miR-182/miR-217 signaling and p27/CDK6 regulation. Oncotarget. 2020; 11(29):2847-2862. PMC: 7381096. DOI: 10.18632/oncotarget.27675. View

10.

Nanbo A, Kawanishi E, Yoshida R, Yoshiyama H . Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells. J Virol. 2013; 87(18):10334-47. PMC: 3753980. DOI: 10.1128/JVI.01310-13. View

11.

Chen L, Huang H, Zhang W, Ding F, Fan Z, Zeng Z . Exosomes Derived From T Regulatory Cells Suppress CD8+ Cytotoxic T Lymphocyte Proliferation and Prolong Liver Allograft Survival. Med Sci Monit. 2019; 25:4877-4884. PMC: 6618337. DOI: 10.12659/MSM.917058. View

12.

Zhu Y, Howard G, Pittman K, Boykin C, Herring L, Wilkerson E . Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through RhoA-NF-κB. Mol Cancer Res. 2019; 17(9):1910-1919. PMC: 6774348. DOI: 10.1158/1541-7786.MCR-19-0024. View

13.

Johnson S, Dempsey C, Chadwick A, Harrison S, Liu J, Di Y . Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia. Blood. 2016; 128(3):453-6. DOI: 10.1182/blood-2015-12-688051. View

14.

Yin K, Wang S, Zhao R . Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. Biomark Res. 2019; 7:8. PMC: 6450000. DOI: 10.1186/s40364-019-0159-x. View

15.

Chen J, Wang S, Jia S, Ding G, Jiang G, Cao L . Integrated Analysis of Long Non-Coding RNA and mRNA Expression Profile in Pancreatic Cancer Derived Exosomes Treated Dendritic Cells by Microarray Analysis. J Cancer. 2018; 9(1):21-31. PMC: 5743708. DOI: 10.7150/jca.21749. View

16.

Thongboonkerd V . Roles for Exosome in Various Kidney Diseases and Disorders. Front Pharmacol. 2020; 10:1655. PMC: 7005210. DOI: 10.3389/fphar.2019.01655. View

17.

Yao Q, Chen J, Cao H, Orth J, McCaffery J, Stan R . Caveolin-1 interacts directly with dynamin-2. J Mol Biol. 2005; 348(2):491-501. DOI: 10.1016/j.jmb.2005.02.003. View

18.

Bobrie A, Krumeich S, Reyal F, Recchi C, Moita L, Seabra M . Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 2012; 72(19):4920-30. DOI: 10.1158/0008-5472.CAN-12-0925. View

19.

Lyu H, Xiao Y, Guo Q, Huang Y, Luo X . The Role of Bone-Derived Exosomes in Regulating Skeletal Metabolism and Extraosseous Diseases. Front Cell Dev Biol. 2020; 8:89. PMC: 7090164. DOI: 10.3389/fcell.2020.00089. View

20.

Fan J, Zhou Z, Luo Y, Luo Q, Chen S, Zhao J . Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway. Neoplasia. 2021; 23(7):692-703. PMC: 8233173. DOI: 10.1016/j.neo.2021.05.004. View